Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis
Clinical trial NCT04271735 · COMPLETED
Trial details
- NCT number
- NCT04271735
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-26
- Primary completion
- 2022-12-19
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.